W. Schramm

2.4k total citations
67 papers, 1.9k citations indexed

About

W. Schramm is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, W. Schramm has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 18 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in W. Schramm's work include Hemophilia Treatment and Research (52 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Platelet Disorders and Treatments (12 papers). W. Schramm is often cited by papers focused on Hemophilia Treatment and Research (52 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Platelet Disorders and Treatments (12 papers). W. Schramm collaborates with scholars based in Germany, United States and United Kingdom. W. Schramm's co-authors include A. Gringeri, Thomas D. Szucs, Paul Giangrande, Marianne Jochum, Hans Fritz, Erik Berntorp, Karin Berger, Kathelijn Fischer, Jan Astermark and K. H. Duswald and has published in prestigious journals such as Anesthesiology, Journal of Thoracic and Cardiovascular Surgery and Intensive Care Medicine.

In The Last Decade

W. Schramm

66 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Schramm Germany	21	1.5k	327	234	222	118	67	1.9k
Pia Petrini Sweden	30	2.7k 1.9×	667 2.0×	296 1.3×	363 1.6×	66 0.6×	76	3.0k
Connie H. Miller United States	29	1.8k 1.3×	449 1.4×	165 0.7×	392 1.8×	194 1.6×	74	2.4k
Cristina Santoro Italy	21	1.2k 0.9×	501 1.5×	116 0.5×	245 1.1×	76 0.6×	106	1.5k
M. J. Manco‐Johnson United States	12	1.1k 0.8×	221 0.7×	237 1.0×	205 0.9×	140 1.2×	14	1.5k
Britta A. P. Laros‐van Gorkom Netherlands	19	1.0k 0.7×	253 0.8×	177 0.8×	55 0.2×	226 1.9×	49	1.2k
Madhvi Rajpurkar United States	19	584 0.4×	114 0.3×	116 0.5×	112 0.5×	116 1.0×	74	979
Nathan T. Connell United States	16	600 0.4×	232 0.7×	178 0.8×	61 0.3×	204 1.7×	68	1.2k
Dora Bachir France	23	1.1k 0.8×	1.3k 4.1×	82 0.4×	151 0.7×	92 0.8×	45	1.7k
Leonardo Di Gennaro Italy	14	291 0.2×	627 1.9×	53 0.2×	324 1.5×	73 0.6×	31	872
Kristi J. Smock United States	15	399 0.3×	90 0.3×	167 0.7×	95 0.4×	106 0.9×	66	832

Countries citing papers authored by W. Schramm

Since Specialization

Citations

This map shows the geographic impact of W. Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Schramm more than expected).

Fields of papers citing papers by W. Schramm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Schramm. The network helps show where W. Schramm may publish in the future.

Co-authorship network of co-authors of W. Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of W. Schramm. A scholar is included among the top collaborators of W. Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Schramm. W. Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giangrande, Paul, et al.. (2017). Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates. Haemophilia. 23(3). 370–375. 13 indexed citations

Şerban, M., et al.. (2014). Risiken und Herausforderungen orthopädischer invasiver Eingriffe bei Hämophilie in Ländern mit eingeschränkten Ressourcen. Hämostaseologie. 34. 1 indexed citations

Şerban, M., et al.. (2014). Risks and challenges of orthopaedic invasive interventions in haemo -philia in a low-resource country. Hämostaseologie. 34(S 01). S30–S35. 1 indexed citations

Rieger, Anja & W. Schramm. (2013). Morbidity and mortality of haemophilia patients in Germany. Hämostaseologie. 33(S 01). S5–S9. 4 indexed citations

Siebeck, Matthias, et al.. (2012). Long-term outcome of an unusual haemophilic pseudotumour. Hämostaseologie. 32(S 01). S43–S44. 7 indexed citations

Krebs, H., et al.. (2010). Hämophilie-Patienten in Deutschland 2008/2009. Hämostaseologie. 30(S 01). S9–S14. 2 indexed citations

Rentz, Anne M., Emuella Flood, Carmen Altisent, et al.. (2008). Cross‐cultural development and psychometric evaluation of a patient‐reported health‐related quality of life questionnaire for adults with haemophilia. Haemophilia. 14(5). 1023–1034. 71 indexed citations

Schramm, W., et al.. (2008). Todesursachen bei Hämophilie-Patienten in Deutschland 2006/2007. Hämostaseologie. 28(S 01). S5–S11. 2 indexed citations

Colvin, B T, Jan Astermark, Kathelijn Fischer, et al.. (2008). European principles of haemophilia care. Haemophilia. 14(2). 361–374. 166 indexed citations

10.

Feldman, B. M., Louis M. Aledort, Monika Bullinger, et al.. (2007). The economics of haemophilia prophylaxis: governmental and insurer perspectives. PROCEEDINGS OF THE SECOND INTERNATIONAL PROPHYLAXIS STUDY GROUP (IPSG) SYMPOSIUM. Haemophilia. 13(6). 745–749. 15 indexed citations

11.

El‐Maarri, Osman, Jochen Graw, Jörg Schröder, et al.. (2005). Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. Journal of Thrombosis and Haemostasis. 3(2). 332–339. 62 indexed citations

12.

Berger, Karin, L. Frey, M. Spannagl, & W. Schramm. (2005). Gesundheitsökonomische Aspekte der Anwendung von Blut- und Plasmaprodukten. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 49(1). 64–72. 5 indexed citations

13.

Bohn, Rhonda L., W. Schramm, Monika Bullinger, Marijke van den Berg, & Victor S. Blanchette. (2004). Outcome measures in haemophilia: more than just factor levels. Haemophilia. 10(s1). 2–8. 17 indexed citations

14.

Albert, T., Johannes Oldenburg, Jan A. Graw, et al.. (2003). Charakterisierung von Faktor-VIII-Antikörperepitopen mit Faktor-VIII-Peptid-Bibliotheken. Hämostaseologie. 23(1). 13–17. 6 indexed citations

15.

Graw, Jan A., et al.. (2003). Erfassung und Bewertung phänotypischer Parameter von Hämophilie-A-Patienten und Korrelation mit dem Genotyp. Hämostaseologie. 23(1). 24–27. 1 indexed citations

16.

Schramm, W. & Karin Berger. (2003). Economics of prophylactic treatment. Haemophilia. 9(s1). 111–116. 24 indexed citations

17.

Spannagl, M. & W. Schramm. (1999). Hämostaseologie - rationale Diagnostik. Der Internist. 40(6). 657–667. 1 indexed citations

18.

Miners, A, Rhonda L. Bohn, Keith Hoots, et al.. (1999). Economic aspects of haemophilia care. Haemophilia. 5(3). 216–219. 14 indexed citations

19.

Werba, A., et al.. (1993). The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia. 48(4). 301–303. 35 indexed citations

20.

Dietrich, W., M. Spannagl, W. Schramm, et al.. (1991). The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 102(4). 505–514. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact